CLOV logo

Clover Health Investments, Corp.NasdaqGS:CLOV Stock Report

Market Cap US$1.3b
Share Price
US$2.62
My Fair Value
US$4.31
39.2% undervalued intrinsic discount
1Y-1.5%
7D18.6%
Portfolio Value
View

Clover Health Investments, Corp.

NasdaqGS:CLOV Stock Report

Market Cap: US$1.3b

CLOV Community Fair Values

Create Narrative

See what 72 others think this stock is worth. Follow their fair value or set your own to get alerts.

Clover Health Investments, Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Clover Health Investments
Historical stock prices
Current Share PriceUS$2.62
52 Week HighUS$4.87
52 Week LowUS$2.12
Beta1.92
1 Month Change-12.08%
3 Month Change-26.20%
1 Year Change-1.50%
3 Year Change-16.56%
5 Year Change-74.78%
Change since IPO-74.31%

Recent News & Updates

Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential

Aug 11

Recent updates

Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential

Aug 11

Clover Health Investments, Corp. (NASDAQ:CLOV) Could Be Riskier Than It Looks

May 09
Clover Health Investments, Corp. (NASDAQ:CLOV) Could Be Riskier Than It Looks

Analysts Are Updating Their Clover Health Investments, Corp. (NASDAQ:CLOV) Estimates After Its First-Quarter Results

May 09
Analysts Are Updating Their Clover Health Investments, Corp. (NASDAQ:CLOV) Estimates After Its First-Quarter Results
author-image

Tech-Driven Care And Home Services Will Secure Long-Term Success

Enhanced star ratings will increase future revenue and provide long-term stability due to improved financial benchmarks.

Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth

Mar 07

We Think Clover Health Investments (NASDAQ:CLOV) Can Afford To Drive Business Growth

Feb 25
We Think Clover Health Investments (NASDAQ:CLOV) Can Afford To Drive Business Growth

Clover Health: Undervalued Turnaround Play With Promising SaaS Potential

Jan 16

Recent Earnings Disappointment Could Be An Ideal Buying Opportunity For Clover Health

Dec 21

Clover Health: Buy The Dip, Reap The Rewards

Nov 18

Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Nov 08
Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Clover Health's Rally: The Payoff Of A Profitable Pivot

Nov 06

There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Oct 03
There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Clover Health: Changing Business Model, Seeking Profitability

Oct 03

Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success

Aug 15

Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Aug 14
Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Aug 06
Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jun 12
Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Apr 20
Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Mar 16
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Mar 06
Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Clover Health: Its Luck May Have Ran Out

Feb 26

Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Nov 21
Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Jul 07
We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Shareholder Returns

CLOVUS HealthcareUS Market
7D18.6%6.9%1.9%
1Y-1.5%-31.0%19.4%

Return vs Industry: CLOV exceeded the US Healthcare industry which returned -31% over the past year.

Return vs Market: CLOV underperformed the US Market which returned 19.4% over the past year.

Price Volatility

Is CLOV's price volatile compared to industry and market?
CLOV volatility
CLOV Average Weekly Movement10.7%
Healthcare Industry Average Movement6.8%
Market Average Movement6.4%
10% most volatile stocks in US Market17.6%
10% least volatile stocks in US Market3.1%

Stable Share Price: CLOV has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: CLOV's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a570Andrew Toywww.cloverhealth.com

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could.

Clover Health Investments, Corp. Fundamentals Summary

How do Clover Health Investments's earnings and revenue compare to its market cap?
CLOV fundamental statistics
Market capUS$1.34b
Earnings (TTM)-US$42.12m
Revenue (TTM)US$1.61b
0.8x
P/S Ratio
-31.9x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CLOV income statement (TTM)
RevenueUS$1.61b
Cost of RevenueUS$1.22b
Gross ProfitUS$383.65m
Other ExpensesUS$425.77m
Earnings-US$42.12m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.082
Gross Margin23.86%
Net Profit Margin-2.62%
Debt/Equity Ratio0%

How did CLOV perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/14 07:54
End of Day Share Price 2025/08/13 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Clover Health Investments, Corp. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kevin FischbeckBofA Global Research
Richard CloseCanaccord Genuity
Jason CassorlaCitigroup Inc